Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,055 SEK | +2,75% | +17,16% | +15,97% |
Omzet 2021 | 844K 77,14K 72,13K | Omzet 2022 | 1,14 mln. 105K 97,86K | Marktkapitalisatie | 595 mln. 54,4 mln. 50,87 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -156 mln. -14,26 mln. -13,33 mln. | Nettowinst (verlies) 2022 | -168 mln. -15,36 mln. -14,36 mln. | EV/omzet 2021 | 1.710 x |
Nettoliquiditeiten 2021 | 254 mln. 23,23 mln. 21,72 mln. | Nettoliquiditeiten 2022 | 68,47 mln. 6,26 mln. 5,85 mln. | EV/omzet 2022 | 460 x |
K/w-verhouding 2021 |
-10,9
x | K/w-verhouding 2022 |
-3,54
x | Werknemers | 11 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 75,52% |
Recentste transcriptie over Immunovia AB
1 dag | +3,50% | ||
1 week | +17,16% | ||
Lopende maand | +50,22% | ||
1 maand | +55,45% | ||
3 maanden | +12,66% | ||
6 maanden | +273,64% | ||
Lopend jaar | +15,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 01-04-22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 01-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 09-12-16 | |
Peter Andersen
CHM | Chairman | 67 | 01-01-20 |
Michael Löfman
BRD | Director/Board Member | - | 22-05-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,055 | +2,75% | 1 008 622 |
25-04-24 | 2 | -4,76% | 689 247 |
24-04-24 | 2,1 | +9,72% | 1 041 782 |
23-04-24 | 1,914 | -7,31% | 1 067 817 |
22-04-24 | 2,065 | +17,73% | 3 201 853 |
uitgestelde koers Nasdaq Stockholm, 26 april 2024 om 17:29 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+15,97% | 8,31 mln. | |
-12,91% | 18,55 mld. | |
-46,07% | 2,65 mld. | |
+18,15% | 1,81 mld. | |
-3,12% | 1,61 mld. | |
+23,78% | 1,21 mld. | |
-10,69% | 1,03 mld. | |
-20,89% | 896 mln. | |
-18,00% | 686 mln. | |
-7,14% | 680 mln. |